✦ LIBER ✦

Impaired renal function in a patient with diuretic abuse

✍ Scribed by G. Yasuda; T. Takizawa; K. Shibata; N. Hirawa; M. Kihara; Y. Toya; H. Shionoiri; S. Umemura

Book ID: 106288826
Publisher: Springer
Year: 2002
Tongue: English
Weight: 123 KB
Volume: 6
Category: Article
ISSN: 1342-1751
DOI: 10.1007/s101570200010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gabapentin–induced severe myoclonus in a

Gabapentin–induced severe myoclonus in a patient with impaired renal function

✍ M. Holtkamp; A. Halle; H. Meierkord; F. Masuhr 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 116 KB

Drug Dosing in Patients With Impaired Re

Drug Dosing in Patients With Impaired Renal Function

✍ Brater, D C 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 180 KB

Treatment of a patient with impaired ren

Treatment of a patient with impaired renal function with gentamicin-PMMA-beads

✍ G. H. I. M. Walenkamp; T. B. Vree 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 357 KB

Metabolism of the diuretic bumetanide in

Metabolism of the diuretic bumetanide in healthy subjects and patients with renal impairment

✍ M. R. Howlett; G. G. Skellern; W. H. R. Auld; W. R. Murdoch 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 351 KB

The pharmacokinetics and metabolism of orally administered bumetanide were studied in five healthy subjects and in five patients with renal insufficiency. Healthy subjects excreted 51% of the dose as unchanged drug in the urine, whilst the patients with renal insufficiency excreted only 11% of the d

Pharmacokinetics of carteolol in patient

Pharmacokinetics of carteolol in patients with impaired renal function

✍ M. Amemiya; K. Tabei; H. Furuya; Y. Sakairi; Y. Asano 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 503 KB

Pharmacokinetics of tenoxicam in patient

Pharmacokinetics of tenoxicam in patients with impaired renal function

✍ F. F. Horber; T. W. Guentert; E. Weidekamm; P. Heizmann; C. Descoeudres; F. J. F 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 505 KB